digital health companies weight loss glp-1 Management for Men & Women Data Brief: GLP-1 Prescriptions for

Among all, Tirzepatide is projected to grow at a CAGR of 37% over the forecast period

This is especially helpful when you use multiple areas, like thighs and abdomen

Wegovy is a GLP-1 receptor agonist licensed for chronic weight management in adults with obesity or overweight with comorbidities, whilst lisdexamfetamine is a central nervous system stimulant indicated for attention deficit hyperactivity disorder (ADHD)

References 1 VestergaardP

Data on the primary outcome, the composite of all-cause mortality and HF-related hospitalization, was pooled using a random effect meta-analysis with additional subgroup analyses

Approximately 1 in 200 Americans have Graves' disease, an autoimmune condition that speeds metabolism and creates unique challenges for weight management